The Calcium Carbonate Tablets, cataloged under National Stock Number 6505-01-693-3702, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Glaxosmithkline, Llc. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 3 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 4 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-693-3702 |
| Primary Part Number | NDC00135-0178-03 |
| Item Name | Calcium Carbonate Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Glaxosmithkline, Llc |
| Status | ACTIVE |
| Administration | ORAL, CHEWABLE |
| Primary Container Content Quantity | 96.0 TABLETS |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 750.0 MILLIGRAMS CALCIUM CARBONATE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00135-0178-03 PRIMARY | Glaxosmithkline, Llc (USA) |
| NDC70000-0431-01 | Cardinal Health 414, Llc Div Nphs (USA) |
| NDC00135-0140-03 PRIMARY | Glaxosmithkline, Llc (USA) |
| Reference | Meaning |
|---|---|
| NDC00536-1225-22 | 5/9 Secondary reference Dms Pharmaceutical Group Inc |
| 6505NCM216840 | 5/1 Secondary reference Defense Medical Standardization Board |
| TUMS EXTRA STRENGTH | 5/1 Secondary reference Glaxosmithkline, Llc |
| 1589965 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-693-3702 is a Calcium Carbonate Tablets, manufactured by Glaxosmithkline, Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-693-3702 has 3 manufacturer part numbers on file: NDC00135-0178-03 (Glaxosmithkline, Llc), NDC70000-0431-01 (Cardinal Health 414, Llc Div Nphs), NDC00135-0140-03 (Glaxosmithkline, Llc).
Key specifications for NDC00135-0178-03: Administration: ORAL, CHEWABLE; Primary Container Content Quantity: 96.0 TABLETS; Primary Container Type: BOTTLE; Special Features: CALCIUM CARBONATE 750MG CHEWABLE ANTACID TABLET; CONTAINS 300MG ELEMENTAL CALCIUM. ANY FLAVOR, 96 TABLETS PER BOTTLE; STORE BELOW 30 C (86 F) IN ORIGINAL CONTAINER.. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.